ClinicalTrials.Veeva

Menu

Evaluation of Clinical Perfectionism in Parkinson Disease (EPMP-1)

C

Centre Hospitalier Universitaire, Amiens

Status

Unknown

Conditions

Parkinson Disease

Treatments

Behavioral: Completion of scales evaluation

Study type

Interventional

Funder types

Other

Identifiers

NCT02824367
PI2014_843_0002
2013-A01302-43 (Other Identifier)

Details and patient eligibility

About

Scientific studies show that almost half of the people with Parkinson's Disease (PD) suffer of depression and / or anxiety.

Full description

Scientific studies show that almost half of the people with Parkinson's Disease (PD) suffer of depression and / or anxiety. Also, clinicians reported that they exhibit specific personality traits (e.g., rigidity and perfectionism).

To date, few studies used Cognitive Behavioural Therapies (CBT) in people with Parkinson's disease showing promising results. Recently, perfectionism has received particular attention because of it association with many emotional disorders. Thus, some psychometric tools have been developed in order to evaluate different aspects of perfectionism. Yet, none of them has been used in people with Parkinson's disease.

The objective of this study is to investigate whether there is a direct link between Parkinson's disease and perfectionism by using psychometric tools from the CBT literature. Identifying such link would allow to justify the use of CBT in people with Parkinson's disease with the goal in mind to improve their care and quality of life.

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age greater than 18 years
  • Score Mini Mental Scale (MMS) greater than 23
  • For Parkinsonian, Parkinson disease be defined according to the criteria of the Unified Parkinson Disease Rating Scale (UPDRS), with a Hoehn and Yahr stage 1, 2 or 3
  • The control patients present dystonias not within the scope of Parkinson
  • Informed Consent Form signed
  • Patient covered by social insurance

Exclusion criteria

  • Proven Presence of neuropsychological disorders
  • Patients with deep brain stimulation
  • Diagnosis of somatic pathology diagnosed
  • Private Patient freedom or protected adult (under guardianship)

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Parkinsonian
Other group
Description:
Patient Arm: Parkinsonian will complete several scale of evaluation. Behavioral: Completion of scales evaluation
Treatment:
Behavioral: Completion of scales evaluation
Dystonic
Other group
Description:
Comparator Arm: Dystonic patient will complete several scale of evaluation. Behavioral: Completion of scales evaluation
Treatment:
Behavioral: Completion of scales evaluation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems